These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9562116

  • 1. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):72-89. PubMed ID: 9562116
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA, Wright A.
    Clin Infect Dis; 2005 Aug 15; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A, Gogate A.
    Indian J Public Health; 1998 Aug 15; 42(4):126-30. PubMed ID: 10389525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep 15; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa, Zhangireev AA, Sidorenko OA.
    Probl Tuberk Bolezn Legk; 2008 Sep 15; (5):20-2. PubMed ID: 18711814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-tuberculosis drug resistance in two clinics in Ecuador.
    Mertz BL, Douce RW, Brito N.
    Int J Tuberc Lung Dis; 2000 Feb 15; 4(2):115-7. PubMed ID: 10694088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L, Migliori GB, Cassone A.
    Ann Ist Super Sanita; 2007 Feb 15; 43(4):317-9. PubMed ID: 18209265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.